We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current REDX market cap is 71.96M. The company's latest EPS is GBP -0.0852 and P/E is -2.17.
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 3.13M | 5.69M | 10.04M | 18.69M | 4.2M |
Operating Income | -6.16M | -6.95M | -18.06M | -16.2M | -31.76M |
Net Income | -4.32M | -9.21M | -21.58M | -18.01M | -33.16M |
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 6.36M | 32.93M | 39.55M | 62.48M | 25.64M |
Total Liabilities | 4.87M | 30.9M | 26.41M | 29.16M | 22.28M |
Total Equity | 1.49M | 2.03M | 13.13M | 33.32M | 3.36M |
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -4.67M | 395k | -21.38M | -8.47M | -34.75M |
Investing | 32k | -55k | -754k | -241k | -195k |
Financing | 1.87M | 23.47M | 24.14M | 32.98M | -816k |
Market Cap | 71.96M |
Price to Earnings Ratio | -2.17 |
Price to Sales Ratio | 17.13 |
Price to Cash Ratio | 3.98 |
Price to Book Ratio | 21.45 |
Dividend Yield | - |
Shares Outstanding | 388.99M |
Average Volume (1 week) | 71.12k |
Average Volume (1 Month) | 112.2k |
52 Week Change | -38.33% |
52 Week High | 36.00 |
52 Week Low | 17.50 |
Spread (Intraday) | 1 (5.26%) |
Company Name | Redx Pharma Plc |
Address |
block 33 cheshire SK10 4TG |
Website | https://www.redxpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions